CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 53 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $39,118 | +22.2% | 17,082 | +30.2% | 0.00% | – |
| Q4 2021 | $32,000 | -67.0% | 13,118 | -34.3% | 0.00% | – |
| Q3 2021 | $97,000 | +34.7% | 19,954 | -24.5% | 0.00% | -100.0% |
| Q2 2020 | $72,000 | +38.5% | 26,418 | +8.1% | 0.00% | 0.0% |
| Q1 2020 | $52,000 | -71.7% | 24,436 | -46.6% | 0.00% | -50.0% |
| Q1 2019 | $184,000 | -31.9% | 45,785 | -37.7% | 0.00% | -33.3% |
| Q4 2018 | $270,000 | -38.1% | 73,454 | +44.5% | 0.00% | -40.0% |
| Q3 2018 | $436,000 | +164.2% | 50,824 | +237.6% | 0.01% | +150.0% |
| Q2 2018 | $165,000 | +7.1% | 15,053 | +12.5% | 0.00% | 0.0% |
| Q1 2018 | $154,000 | – | 13,378 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $8,746,000 | 1.82% |
| Telemetry Investments, L.L.C. | 263,975 | $705,000 | 0.97% |
| CHI Advisors LLC | 719,132 | $1,920,000 | 0.45% |
| BVF INC/IL | 3,678,626 | $9,822,000 | 0.37% |
| EcoR1 Capital, LLC | 3,579,377 | $9,557,000 | 0.36% |
| Orbimed Advisors | 8,053,298 | $21,502,000 | 0.22% |
| Stonepine Capital Management, LLC | 46,886 | $125,000 | 0.06% |
| Ikarian Capital, LLC | 100,000 | $267,000 | 0.02% |
| ALGERT GLOBAL LLC | 19,737 | $53,000 | 0.02% |
| Windsor Creek Advisors, LLC | 14,786 | $39,000 | 0.01% |